See the latest COVID-19 vaccine news and resources. Learn more.
Resources, links, and suggested best practices for a thoughtful approach to COVID-19 preparation and response in senior living communities.
Please note, the information included here is updated often as we learn about new resources, guidelines, and public health directives.
The FDA has issued a report on considerations on using pulse oximeters and conditions under which they may be less accurate or have limitations.
A new video series created in collaboration with the CDC, HHS, National Institute of Allergy and Infectious Diseases (NIAID), and top healthcare and medical institutions was launched to help healthcare providers better understand and answer common questions about COVID-19 vaccination.
Senior Living Needs Support for Relief & Resources: We are working to tell Congress what resources senior living needs due to COVID-19.
LEARN MORE
The Centers for Disease Control and Prevention (CDC) has a dedicated site for COVID-19 and has posted guidance, in order of recency. Here are some direct links you may find useful:
As new information emerges, the CDC continually updates several special topic pages that may be useful:
Read an updated a situation summary from the Centers for Disease Control and Prevention.
The U.S. Food and Drug Administration’s FAQs continually provides updates on COVID-19 testing, treatments, and fraud warnings. It has uncovered more than 700 fraudulent and unproven products under its Operation Quack Hack campaign. Here are direct links to some important lists:
Share positive messages of connection, hope, and appreciation with seniors. Post a photo, video, message, or song (get creative!), that our network of senior living communities can share with their residents. #SharingForSeniors JOIN TODAY
The FDA authorized monoclonal antibody (mAb) treatments for COVID-19 in November 2020 after these treatments were shown to be effective at combatting the disease. Since then, a pilot program was established by the U.S. Department of Health and Human Services (HHS) to increase access to bamlanivimab (Eli Lilly) for COVID-19 in high-risk, eligible individuals residing or working in long-term care facilities, including assisted living. The program utilizes home infusion providers – in partnership with community staff – to identify, assess, coordinate, dispense, and administer monoclonal antibody therapies in these healthcare settings.
We encourage interested senior living communities to have a protocol mapped out ahead of time, as these treatments must be administered ASAP upon confirmation of COVID-19 symptoms. Without a plan in place, treatment will be delayed.
Assisted living communities and skilled nursing facilities experiencing an outbreak of COVID-19 can locate a home infusion provider from the National Home Infusion Association’s HHS Bamlanivimab Pilot Provider List. Infusion providers are available in most states and can be located using this map.
Once a physician’s order has been issued following a positive COVID-19 test, these providers:
Additional Resources:
Argentum, its executive staff and consultants, have attempted to provide the best possible information as a service to the association’s membership in a situation that is very quickly evolving and about which so much is unknown. Therefore, Argentum can provide no assurances nor even make any representations about the reliability or accuracy of this information. Each senior living company and each community must make decisions that each regards as in the best interests of the health and safety of the residents. Argentum specifically disclaims responsibility or liability for the information it is providing from any legal, regulatory, medical, or compliance point of view.
Get updates on the latest news impacting senior living through our Argentum Daily newsletter.
